Geoffroy Pierre A, Decio Valentina, Pirard Philippe, Bouaziz Olivier, Corruble Emmanuelle, Kovess-Masfety Viviane, Lejoyeux Michel, Messika Jonathan, Pignon Baptiste, Perduca Vittorio, Regnault Nolwenn, Tebeka Sarah
Département de psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hopital Bichat -Claude Bernard, F-75018 Paris, France; GHU Paris - Psychiatry & Neurosciences, 1 rue Cabanis, 75014 Paris, France; Université Paris Cité, NeuroDiderot, Inserm, FHU I2-D2, F-75019 Paris, France; CNRS UPR 3212, Institute for Cellular and Integrative Neurosciences, F-67000 Strasbourg, France.
Santé publique France, French National Public Health Agency, Non Communicable Diseases and Trauma Division, F-94415 Saint-Maurice, France.
J Affect Disord. 2024 Apr 1;350:332-339. doi: 10.1016/j.jad.2024.01.121. Epub 2024 Jan 14.
Although hospitalisation for COVID-19 is associated with a higher post-discharge risk of mood disorders, including major depressive disorder (MDD) and bipolar disorder (BD), this risk has not been compared to that following hospitalisation for a reason other than COVID-19.
Using data from France's National Health Data System (SNDS) database, we compared patients hospitalised for mood disorders in the 12 months following COVID-19/another reason hospitalisation.
96,313 adult individuals were hospitalised for COVID-19, and 2,979,775 were hospitalised for another reason. In the 12 months post-discharge, 110,976 (3.83 %) patients were hospitalised for mood disorders. In unadjusted analyses, patients initially hospitalised for COVID-19 (versus another reason) were more likely to be subsequently hospitalised for a mood disorder (4.27 % versus 3.82 % versus, respectively, p < 0.0001). These patients were also more likely to have a history of mood disorders, especially depressive disorders (6.45 % versus 5.77 %, respectively, p < 0.0001). Women, older age, lower social deprivation, a history of mood disorders, longer initial hospitalisation (COVID-19 or other), and a higher level of clinical care during initial hospitalisation were all significantly associated with the risk of subsequent hospitalisation for MDD and BD. In contrast, after adjusting for all these factors, persons initially hospitalised for COVID-19 were less likely to be subsequently hospitalised for MDD (OR = 0.902 [0.870-0.935]; p < 0.0001). No difference between both groups was observed for BD.
Other reasons were not separately studied.
After adjusting for confounding factors, initial hospitalisation for COVID-19 versus for another reason was associated with a lower risk of hospitalisation for a mood disorder.
尽管因新冠肺炎住院与出院后发生情绪障碍(包括重度抑郁症(MDD)和双相情感障碍(BD))的风险较高有关,但尚未将此风险与因新冠肺炎以外的原因住院后的风险进行比较。
利用法国国家卫生数据系统(SNDS)数据库中的数据,我们比较了在因新冠肺炎/其他原因住院后的12个月内因情绪障碍住院的患者。
96313名成年人因新冠肺炎住院,2979775名成年人因其他原因住院。在出院后的12个月内,110976名(3.83%)患者因情绪障碍住院。在未调整的分析中,最初因新冠肺炎住院(相对于其他原因)的患者随后因情绪障碍住院的可能性更大(分别为4.27%对3.82%,p<0.0001)。这些患者也更有可能有情绪障碍病史,尤其是抑郁症(分别为6.45%对5.77%,p<0.0001)。女性、年龄较大、社会剥夺程度较低、有情绪障碍病史、最初住院时间较长(新冠肺炎或其他原因)以及最初住院期间的临床护理水平较高均与随后因MDD和BD住院的风险显著相关。相比之下,在对所有这些因素进行调整后,最初因新冠肺炎住院的人随后因MDD住院的可能性较小(OR=0.902[0.870-0.935];p<0.0001)。两组在BD方面未观察到差异。
未分别研究其他原因。
在调整混杂因素后,因新冠肺炎而非其他原因的初次住院与情绪障碍住院风险较低相关。